BioStem Technologies (OTC: BSEM)
Milan Hejda, Jr., CPA, currently serves as the Controller at BioStem Technologies (OTC: BSEM) since 2024. Prior to this role, Milan held the position of Controller at Eagle Football Holdings Ltd. from 2022 to 2023 and at Tropical Smoothie Cafe from 2019 to 2022. Milan also has significant experience in the financial sector, having worked as a Sr SEC Manager at Voya Financial from 2017 to 2019 and as an SEC Manager at NextEra Energy, Inc. from 2010 to 2017. Earlier in the career, Milan was an SEC Senior at both Dycom Industries, Inc. from 2008 to 2010 and Crowe from 2005 to 2008. Milan earned a BBA in Accounting and a BBA in Operations Management from Florida Atlantic University.
This person is not in any offices
BioStem Technologies (OTC: BSEM)
BioStem Technologies is a leading innovator focused on harnessing the natural properties of perinatal tissue in the development, manufacture, and commercialization of allografts for regenerative therapies. The Company is focused on manufacturing products that change lives, leveraging its proprietary BioRetain processing method. BioRetain has been developed by applying the latest research in regenerative medicine, focused on maintaining growth factors and preserving tissue structure. BioStem Technologies' quality management system and standard operating procedures have been reviewed and accredited by the American Association of Tissue Banks ("AATB"). These systems and procedures are established per current Good Tissue Practices ("cGTP") and current Good Manufacturing Processes ("cGMP"). Our portfolio of quality brands includes VENDAJE, VENDAJE AC, and VENDAJE OPTIC. Each BioStem Technologies placental allograft is processed at the Company's FDA registered and AATB accredited site in Pompano Beach, Florida.